欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号ES/V/0281/001
药品名称HEMOSILATE 125 mg/ml solution for injection
活性成分
    • etamsylate 125.0 mg/ml
剂型Solution for injection
上市许可持有人ECUPHAR VETERINARIA SLU Avda Rio de Janeiro 60-66 08016 Barcelona SPAIN
参考成员国 - 产品名称Spain (ES)
HEMOSILATE 125 mg/ml solución inyectable
互认成员国 - 产品名称
    • Austria (AT)
    • Belgium (BE)
      Hemosilate 125 mg/ml
    • Germany (DE)
    • France (FR)
    • Netherlands (NL)
    • Czechia (CZ)
    • Ireland (IE)
    • Slovenia (SI)
    • Slovakia (SK)
    • Estonia (EE)
    • Hungary (HU)
    • Denmark (DK)
    • Romania (RO)
    • Norway (NO)
    • Poland (PL)
    • Finland (FI)
    • Sweden (SE)
    • United Kingdom (Northern Ireland) (XI)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Cyprus (CY)
    • Malta (MT)
    • United Kingdom (GB)
许可日期2018/02/28
最近更新日期2022/07/28
药物ATC编码
    • QB02BX01 etamsylate
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase